Powered by
ANN ARBOR — Organizers of the Midwest Growth Capital Symposium announced that Louis Cannon, M.D., founder and senior managing director of Biostar Capital, and Dug Song, co-founder and president of …
ANN ARBOR–The tactile display developer NewHpatics announced that it had been awarded a Phase II Small Business Innovation Research grant from the National Science Foundation. This $1 million SBIR grant …
BLOOMFIELD HILLS–Zivo Bioscience Inc. (NASDAQ: ZIVO), a biotech and agriculture-tech research and development company developing medicines and nutritional products from algae cultures, announced a $1 million unsecured six-month loan from …
LAKELAND–Abionyx Pharma, a startup biotech company with operations in Michigan and France, announced its strategy in ophthalmology and new positive preclinical results in two technological platforms: apotherapy and biovectorisation. Cyrille …
DETROIT–Freestyle Partners LLC announced that a surface reflectivity study demonstrated that a filtered Far UV-C portable, handheld device when used as intended does not generate harmful amounts of reflected UV-C …
ANN ARBOR–HistoSonics, developers of non-invasive sonic beam therapy called histotripsy, announced that the U.S. Food and Drug Administration has approved the company sponsored #HOPE4KIDNEY Trial, which is designed to evaluate the …
DETROIT–The cybersecurity startup Hush has been selected for the 2023 accelertor program of MissionLink, which connects innovative startups with national security insiders, commercial sector customers, and investors. These connections place …
NOVI–Our Next Energy Inc., the Novi-based energy storage technology company, today announced it has closed a $300 million Series B capital raise at a post-money valuation of $1.2 billion. The round was led by the Los Angeles venture capital firm Fifth Wall and the San …
ANN ARBOR—Renaissance Venture Capital, a “fund of funds”—a venture fund that invests in other venture funds—will hold its next UnDemo Day for startup founders on Wednesday, April 27. This version …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR), developers of a new class of cholesterol-lowering drugs, announced a 40 percent work force reduction and said it would focus its marketing efforts more …